Leadership Team
Catheter Precision is led by a dedicated team with industry knowledge and overseen by a board of directors with decades of experience and proven track records.
David Jenkins
Chief Executive Officer
David Jenkins has been in the medical device field for over thirty years, all with small companies. In addition to Catheter Precision, Inc., he has previously operated two other cardiac electrophysiology companies, as CEO and Chairman: Arrhythmia Research Technology, Inc., and EP MedSystems, Inc. In addition, he founded Transneuronix, Inc., a company in the implantable neurostimulator market, focused on obesity and weight loss. He began his career as a CPA with Coopers and Lybrand in Austin Texas.
Mr. Jenkins holds a BS degree in accounting from the University of Kansas, and a master’s in public accounting degree from the University of Texas at Austin.
Phil Anderson
Chief Financial Officer
Mr. Anderson served as the Chief Financial Officer of Heritage Distilling Corporation, an adult beverage distiller, from August 2021 to November 2022. From August 2020 to June 2021, he served as Chief Financial Officer of Crown Electrokinetics Corp., a pre-revenue technology/hardware company in the areas of smart windows, fiber optics and water quality solutions. Phil also served as Chief Financial Officer of Kubient, Inc., a supplier of fraud detection and prevention solutions to the global digital advertising market, from June 2019 to January 2020. Prior to serving as a CFO Mr. Anderson was a hedge fund partner for 17 years focused on investing in small and microcap companies.
Phil received a Bachelor of Arts in Business Management from Ithaca College and an MBA with concentration in Finance from Hofstra University.
Marie-Claude Jacques
Chief Commercialization Officer
Marie-Claude Jacques has been a part of the medical device field for over 15 years. Prior to her time at Boston Scientific, she began her career with Baylis Medical and was an integral part in growing and scaling the sales US business. Mrs. Jacques led the company to double digit sales growth for consecutive years and participated in market development which led to the acquisition by Boston Scientific in 2022.
Marie-Claude has a bachelor’s degree in microbiology from Université Laval and a Master’s degree in Business Administration from University of Warwick.
Missiaen Huck
Chief Operating Officer
Ms. Huck has been in the medical device field since 2009. Initially she began her career in marketing but has since held management positions in multiple roles including clinical, regulatory and quality and manufacturing/operations, giving her a unique understanding of several departments.
Ms. Huck holds a bachelor’s degree in Journalism and Communications from the University of South Carolina.